Results for

Medical Nutrition Equity Act of2020 This bill expands coverage under Medicare, Medicaid, other specified federal health care programs, and private health insurance to include foods, vitamins, and individual amino acids that are medically necessary for the management of certain digestive and metabolic disorders and conditions.

Medical Nutrition Equity Act of2019 This bill expands coverage under Medicare, Medicaid, other specified federal health-care programs, and private health insurance to include foods, vitamins, and individual amino acids that are medically necessary for the management of certain digestive and metabolic disorders and conditions.

Liver Illness Visibility, Education, and Research Act of 2019 This bill expands and coordinates activities related to the research of liver cancer and liver disease, including causes, prevention, detection, and treatment. Specifically, the National Cancer Institute must establish an inter-institute working group to coordinate efforts to cure liver cancer and liver disease, including research into such cases resulting from hepatitis B, and may award grants to develop preventative and diagnostic measures as well as support for experimental treatment options. The bill further establishes grant programs, administered by the Centers for Disease Control and Prevention, to support liver disease prevention services, diagnostics, and hepatitis tracking programs and to raise awareness about liver disease within high-risk communities. The renamed National Institute of Diabetes and Digestive, Kidney, and Liver Diseases also must prioritize programs addressing liver disease, including (1) establishing a national clearinghouse for patient data and (2) developing or expanding the centers for research of liver disease.

Liver Illness Visibility, Education, and Research Act of 2019 This bill expands and coordinates activities related to the research of liver cancer and liver disease, including causes, prevention, detection, and treatment. Specifically, the National Cancer Institute must establish an inter-institute working group to coordinate efforts to cure liver cancer and liver disease, including research into such cases resulting from hepatitis B, and may award grants to develop preventative and diagnostic measures as well as support for experimental treatment options. The bill further establishes grant programs, administered by the Centers for Disease Control and Prevention, to support liver disease prevention services, diagnostics, and hepatitis tracking programs and to raise awareness about liver disease within high-risk communities. The renamed National Institute of Diabetes and Digestive, Kidney, and Liver Diseases also must prioritize programs addressing liver disease, including (1) establishing a national clearinghouse for patient data and (2) developing or expanding the centers for research of liver disease.

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of2019 This bill allows the National Institutes of Health to expand, intensify, and coordinate its activities with respect to functional gastrointestinal and motility disorders (FGIMDs), including by * expanding basic and clinical research into FGIMDs by implementing the research recommendations of the National Commission on Digestive Diseases, * providing support for the establishment of centers of excellence on FGIMDs, * supporting innovative approaches to educating health care providers and patients regarding strategies that improve patient-provider relationships and care, * directing the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to provide the necessary funding for the continued expansion and advancement of the FGIMDs research portfolio, and * directing NIDDK and the Eunice Kennedy Shriver National Institute of Child Health and Human Development to expand research into FGIMDs that impact children. The Department of Health and Human Services may engage in public awareness and education activities to increase understanding and recognition of FGIMDs.

National Commission on Scleroderma and Fibrotic Diseases Act of2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

National Commission on Scleroderma and Fibrotic Diseases Act of2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

This resolution expresses support for the goals and ideals of National Ostomy Awareness Day. (Ostomy is type of surgery that creates an opening in the abdomen that allows for the removal of bodily waste when an individual has lost normal functions of the digestive or urinary systems due to birth defects, colorectal cancer, bladder cancer, Crohn's disease, ulcerative colitis, or other medical conditions.)

This resolution expresses support for the goals and ideals of National Ostomy Awareness Day. (Ostomy is type of surgery that creates an opening in the abdomen that allows for the removal of bodily waste when an individual has lost normal functions of the digestive or urinary systems due to birth defects, colorectal cancer, bladder cancer, Crohn's disease, ulcerative colitis, and other medical conditions.)

This resolution designates December 3, 2019, as National Phenylketonuria Awareness Day. (Phenylketonuria or PKU is a rare, inherited metabolic disorder that can cause intellectual disability and other neurological problems.)

Chronic Wasting Disease Management Act This bill requires the Department of Agriculture (USDA) to support state and tribal efforts to address chronic wasting disease. The transmissible disease afflicts deer, elk, and moose populations. In addition, USDA must make grants to research centers to support efforts to expand and accelerate applied research on the disease. Land management agencies of the USDA and the Department of the Interior must work cooperatively with states in researching the disease and implementing state management strategies to reduce the spread and prevalence of the disease.

Study, Treat, Observe, and Prevent Neglected Diseases of Poverty Act or the STOP Neglected Diseases of Poverty Act This bill directs the Department of Health and Human Services (HHS) to address neglected diseases of poverty in the United States. Among other activities, HHS must establish an interagency task force to provide recommendations to address neglected diseases of poverty in the United States; provide grants to states to implement surveillance systems to determine the prevalence, incidence, and distribution of such diseases; and increase awareness of neglected diseases of poverty among health care providers and the public.

Chronic Wasting Disease Management Act This bill requires the Animal and Plant Health Inspection Service-Wildlife Services to support state and tribal efforts to address chronic wasting disease. The transmissible disease afflicts deer, elk, and moose populations. The agency must make grants to research centers to support efforts to expand and accelerate applied research on the disease. Land management agencies of the Department of Agriculture and the Department of the Interior must work cooperatively with states in researching the disease and implementing state response plans to reduce the spread and prevalence of the disease.

Stamp Out Lyme Disease Act This bill directs the U.S. Postal Service to issue a Lyme Disease Research Semipostal Stamp, with all proceeds being transferred to the National Institute of Allergy and Infectious Diseases.

Younger Onset Alzheimer's Disease Act This bill makes individuals with younger-onset Alzheimer's disease (i.e., individuals who experienced onset of the disease before age 60) eligible for certain federal grants and programs that support older adults. Under current law, these grants and programs serve only individuals 60 and older.

Chronic Disease Management Act of 2019 This bill allows high deductible health plans to provide treatment for chronic diseases without requiring a plan deductible.